Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema
- 31 March 2000
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (3) , 204-213
- https://doi.org/10.1053/rmed.1999.0720
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S.Diabetes Care, 1998
- Building a National Strategy for the Prevention and Management of and Research in Chronic Obstructive Pulmonary DiseaseNational Heart, Lung, and Blood Institute Workshop SummaryPublished by American Medical Association (AMA) ,1997
- Costs of HIV+/AIDS at CD4+ Counts Disease Stages Based on Treatment ProtocolsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Definitions, Epidemiology, Pathophysiology, Diagnosis, and StagingAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Management of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1993
- Economic appraisal of asthma and COPD care: A literature review 1980–1991Social Science & Medicine, 1992
- Medical costs of coronary artery disease in the United StatesThe American Journal of Cardiology, 1990
- Clinical EconomicsJAMA, 1989
- Trends in COPD Morbidity and Mortality in the United StatesAmerican Review of Respiratory Disease, 1989
- The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis.American Journal of Public Health, 1980